TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 05 2024
0mins
Source: Globenewswire
Leadership Changes at Scienture: TRxADE Health, Inc. announced the appointment of Narasimhan Mani, Ph.D., MBA as President of its subsidiary Scienture, with Shankar Hariharan continuing as CEO and Rahul Surana promoted to Executive VP and COO.
Background of New Appointees: Dr. Mani brings over 25 years of experience in the pharmaceutical industry, while Dr. Hariharan has a notable history of leadership in pharmaceutical businesses, contributing to significant revenue growth and product development.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
